Neuroimaging reveals disease staging in Alzheimer’s diagnosed individuals, suggesting better management approaches.
The individualized staging system can accurately assess disease severity, enabling risk stratification at ultra-early pathological stages and facilitating precise AD management.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: